Table of Contents

Clinical Studies

• You have access

  Dynamic Contrast-enhanced CT to Evaluate Early Response in Neuroendocrine Liver Metastases Treated With Everolimus and Radiation

  JOHN MONTE HUDSON, SIMRON SINGH, LAURENT MILOT, CHIRAG PATEL, COLLEEN BAILEY, VICTOR RODRIGUEZ-FREIXINOS, DAVID CHAN, JULIE HALLET, CALVIN LAW and STEN MYREHAUG

  Anticancer Research July 2022, 42 (7) 3523-3527; DOI: https://doi.org/10.21873/anticanres.15838
• Open Access

  Long-term Outcomes of Radiation Therapy for Prostate Cancer in Elderly Patients Aged ≥75 Years

  ERINA NAKANISHI, TAKERO HIRATA, KEISUKE TAMARI, FUMIAKI ISOHASHI, OSAMU SUZUKI, KAZUHIKO HAYASHI, YUJI SEO, YUICHI AKINO, YASUTOSHI FUMIMOTO, KOJI HATANO, ATSUNARI KAWASHIMA, MOTOHIDE UEMURA, SHINICHI SHIMIZU, NORIO NONOMURA and KAZUHIKO OGAWA

  Anticancer Research July 2022, 42 (7) 3529-3536; DOI: https://doi.org/10.21873/anticanres.15839
• Open Access

  Characterization of the Immunological Status of Hypermutated Solid Tumors in the Cancer Genome Analysis Project HOPE

  YASUTO AKIYAMA, RYOTA KONDOU, AKIRA IIZUKA, HARUO MIYATA, CHIE MAEDA, AKARI KANEMATSU, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KENICHI URAKAMI, YUJI SHIMODA, KEIICHI OHSHIMA, AKIO SHIOMI, YASUHISA OHDE, MASANORI TERASHIMA, KATSUHIKO UESAKA, YASUYUKI HIRASHIMA, YOSHIO KIYOHARA, HIROHISA KATAGIRI, TAKASHI SUGINO, AKIFUMI NOTSU, KEITA MORI, MITSURU TAKAHASHI, HIROTSUGU KENMOTSU and KEN YAMAGUCHI

  Anticancer Research July 2022, 42 (7) 3537-3549; DOI: https://doi.org/10.21873/anticanres.15840
• Open Access

  Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck Cancer

  DIRK RADES, BRITTA WARWAS, FLORIAN CREMERS, KARSTEN GERULL, CHRISTIAN IDEL, KARL L. BRUCHHAGE, SAMER G. HAKIM and STEVEN E. SCHILD

  Anticancer Research July 2022, 42 (7) 3551-3556; DOI: https://doi.org/10.21873/anticanres.15841
• Open Access

  Site-specific Performance of ColonView (CV) Fecal Immunochemical Test (FIT) With Differences Between Proximal and Distal Colorectal Adenoma

  MAARET ESKELINEN, JANNICA MEKLIN, DENISE PEIXOTO GUIMARAES, TUOMAS SELANDER, TAPANI TIUSANEN, KARI SYRJÄNEN and MATTI ESKELINEN

  Anticancer Research July 2022, 42 (7) 3557-3567; DOI: https://doi.org/10.21873/anticanres.15842
• You have access

  Can We Predict a Higher Risk of Urothelial Bladder Cancer With a Simple Blood Test?

  BRENDAN WALLACE, SNIR DEKALO, MHRAN KABHA, ISHAI MINTZ, HAIM MATZKIN and NICOLA J. MABJEESH

  Anticancer Research July 2022, 42 (7) 3569-3573; DOI: https://doi.org/10.21873/anticanres.15843
• You have access

  Evaluation of Durvalumab-induced Lung Toxicity Using a Spontaneous Reporting Database

  JUNYA SATO, KANA NAKANO, TADASHI SHIMIZU and MAYAKO UCHIDA

  Anticancer Research July 2022, 42 (7) 3575-3582; DOI: https://doi.org/10.21873/anticanres.15844
• You have access

  Nestin as a Prognostic Biomarker in High-grade Epithelial Ovarian Cancer Treated by Neoadjuvant Chemotherapy

  HUGO VEYSSIÈRE, GHASSAN ALDARAZI, IOANA MOLNAR, XAVIER DURANDO and NINA RADOSEVIC-ROBIN

  Anticancer Research July 2022, 42 (7) 3583-3594; DOI: https://doi.org/10.21873/anticanres.15845
• You have access

  Polyserositis as a Unique Presentation of Isolated Myeloid Sarcoma: A Case Report

  PALASH ASAWA, URWAT VUSQA, KIRTIVARDHAN VASHISTHA, MIAN TANVEER UD DIN, RAHUL KARNA, FEIFAN CHEN, NINA DUTTON, YAZAN SAMHOURI and SALMAN FAZAL

  Anticancer Research July 2022, 42 (7) 3595-3599; DOI: https://doi.org/10.21873/anticanres.15846
• You have access

  Synchronous Penile Squamous Cell Carcinoma, Bladder Urothelial Carcinoma and Prostate Adenocarcinoma Diagnosed in One Procedure

  FRANK DENG, MAX X. KONG and JINPING LAI

  Anticancer Research July 2022, 42 (7) 3601-3605; DOI: https://doi.org/10.21873/anticanres.15847
• You have access

  Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell Transplantation

  MONIKA RICHERT-PRZYGONSKA, KAMILA JAREMEK, ROBERT DEBSKI, JOANNA KONIECZEK, MONIKA LECKA, MAGDALENA DZIEDZIC, TOMASZ BOGIEL, JAN STYCZYNSKI and KRZYSZTOF CZYZEWSKI

  Anticancer Research July 2022, 42 (7) 3607-3612; DOI: https://doi.org/10.21873/anticanres.15848
• You have access

  Clinical Benefit of Polypectomy With Cutting Current for Colorectal Polyps: A Randomized Controlled Trial

  RYOTA KOYANAGI, MICHITAKA HONDA, HIDETAKA KAWAMURA, KOICHI HAMADA, YOSHINORI HORIKAWA, YOSHIKI SHIWA, KAE TECHIGAWARA, TAKAYUKI NAGAHASHI, TEPPEI MIYAKAWA and SHINICHI KONNO

  Anticancer Research July 2022, 42 (7) 3613-3619; DOI: https://doi.org/10.21873/anticanres.15849
• You have access

  Standardized and Feasible Laparoscopic Approach for Tumors Located in the Caudate Lobe

  YUICHI NAKASEKO, KENEI FURUKAWA, KOICHIRO HARUKI, SHINJI ONDA, JUNGO YASUDA, YOSHIHIRO SHIRAI, NORIMITSU OKUI, KEIGO NAKASHIMA, YUTAKA SUZUKI and TORU IKEGAMI

  Anticancer Research July 2022, 42 (7) 3621-3625; DOI: https://doi.org/10.21873/anticanres.15850
• You have access

  Impact of Histological Variants on Clinical Responses to Pembrolizumab in Patients With Metastatic Urothelial Cancer

  SATOSHI INOUE, NAOTO SASSA, HIDEJI KAWANISHI, YURI YUGUCHI, TOMOHIDE SUZUKI, JUN NAGAYAMA, HIROTAKA MATSUI, YUDAI MIYATA, YUYA SOEDA, KOSUKE TOCHIGI, YUSHI YAMAUCHI, MOTOHIRO MAEDA, IKUO KOBAYASHI, RYOHEI HATTORI, YOSHIHISA MATSUKAWA and MASASHI KATO

  Anticancer Research July 2022, 42 (7) 3627-3636; DOI: https://doi.org/10.21873/anticanres.15851
• You have access

  Impact of Amino Acids Nutrition Following Gastrectomy in Gastric Cancer Patients

  SATORU KIKUCHI, NOBUO TAKATA, SHINJI KURODA, HIBIKI UMEDA, SHUNSUKE TANABE, NAOAKI MAEDA, KOSEI TAKAGI, KAZUHIRO NOMA, YUKO HASEGAWA, KUMIKO NAWACHI, SHUNSUKE KAGAWA, YUZO UMEDA, KENICHI SHIKATA and TOSHIYOSHI FUJIWARA

  Anticancer Research July 2022, 42 (7) 3637-3643; DOI: https://doi.org/10.21873/anticanres.15852
• You have access

  Postoperative Nutrition Status of Patients With Esophago-gastric Junction Cancer With Gastric Tube or Esophago-gastric Reconstruction

  KAZUYA TAKABATAKE, HIROTAKA KONISHI, TAKESHI KUBOTA, ATSUSHI SHIOZAKI, HITOSHI FUJIWARA, TAKUMA OHASHI, TOMOHIRO ARITA, HIROKI SHIMIZU, YUSUKE YAMAMOTO, RYO MORIMURA, HISASHI IKOMA, YOSHIAKI KURIU, KAZUMA OKAMOTO and EIGO OTSUJI

  Anticancer Research July 2022, 42 (7) 3645-3652; DOI: https://doi.org/10.21873/anticanres.15853
• You have access

  Real-world Experience With Pembrolizumab for Advanced-stage Head and Neck Cancer Patients: A Retrospective, Multicenter Study

  TAKAFUMI NAKANO, RYUJI YASUMATSU, KAZUKI HASHIMOTO, RYOSUKE KUGA, TAKAHIRO HONGO, HIDETAKA YAMAMOTO, MIOKO MATSUO, TAKAHIRO WAKASAKI, RINA JIROMARU, TOMOMI MANAKO, SATOSHI TOH, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, YUICHIRO KURATOMI, MASAHIKO TAURA, TORANOSHIN TAKEUCHI and TAKASHI NAKAGAWA

  Anticancer Research July 2022, 42 (7) 3653-3664; DOI: https://doi.org/10.21873/anticanres.15854
• You have access

  Impact of Macroscopic Tumour Consistency and EPIC in Low-grade Appendiceal Neoplasms With Pseudomyxoma Peritonei

  ERNEST CHENG, RAPHAEL SHAMAVONIAN, JASMINE MUI, JOSH KARPES, KERRY CHEN, NIMA AHMADI and DAVID L. MORRIS

  Anticancer Research July 2022, 42 (7) 3665-3673; DOI: https://doi.org/10.21873/anticanres.15855
• You have access

  Independent Validation of a Risk Stratification Model Predicting Survival in Patients With Metastatic Hormone-sensitive Prostate Cancer

  CARSTEN NIEDER and LUKA STANISAVLJEVIC

  Anticancer Research July 2022, 42 (7) 3675-3679; DOI: https://doi.org/10.21873/anticanres.15856
• You have access

  Rare Histologies and Infrequent Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  ALAEDIN RAJHA, POMPILIU PISO, LASZLO HALMY, IVAN PANCZEL, DAN-SEBASTIAN NEDELCUT, ZOLTAN HEROLD, ATTILA MARCELL SZASZ and MIKLOS ACS

  Anticancer Research July 2022, 42 (7) 3681-3692; DOI: https://doi.org/10.21873/anticanres.15857
• You have access

  Risk Factor Analysis for the Occurrence of Severe Adverse Effects in Eribulin Treatment

  YOSHITAKA SAITO, YOH TAKEKUMA, TAKASHI TAKESHITA, TAKURO NOGUCHI, SATOSHI TAKEUCHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA, HIROTOSHI DOSAKA-AKITA and MITSURU SUGAWARA

  Anticancer Research July 2022, 42 (7) 3693-3700; DOI: https://doi.org/10.21873/anticanres.15858
• Open Access

  Clinical Outcomes of Scanning Carbon-ion Radiotherapy for Soft Tissue Sarcoma of the Extremities

  YOSUKE TAKAKUSAGI, ITSUKO SERIZAWA, HIROAKI KOGE, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, DAISAKU YOSHIDA, HIROYUKI KATOH, TORU HIRUMA and TADASHI KAMADA

  Anticancer Research July 2022, 42 (7) 3701-3706; DOI: https://doi.org/10.21873/anticanres.15859
• You have access

  Highly Aggressive Surgery Benefits in Patients With Advanced Ovarian Cancer

  SHINICHI TATE, KYOKO NISHIKIMI, AYUMU MATSUOKA, SATOYO OTSUKA and MAKIO SHOZU

  Anticancer Research July 2022, 42 (7) 3707-3716; DOI: https://doi.org/10.21873/anticanres.15860
• You have access

  Relationship Between Leukotriene Receptor Antagonists on Cancer Development in Patients With Bronchial Asthma: A Retrospective Analysis

  AYAKO MAEDA-MINAMI, MAIKO HOSOKAWA, YUMI ISHIKURA, ATSUTO ONODA, YOHEI KAWANO, KENICHI NEGISHI, SHUJI SHIMADA, TOMOMI IHARA, MASAO SUGAMATA, KEN TAKEDA and YASUNARI MANO

  Anticancer Research July 2022, 42 (7) 3717-3724; DOI: https://doi.org/10.21873/anticanres.15861
• You have access

  Strategy Treatment of cT4b Esophageal Squamous Cell Carcinoma Using Docetaxel, Cisplatin, and 5-Fluorouracil

  MASANOBU NAKAJIMA, HIROTO MUROI, MAIKO KIKUCHI, TSUKASA KUBO, SHUHEI TAKISE, KEISUKE IHARA, MASATOSHI NAKAGAWA, SHINJI MORITA, TAKATOSHI NAKAMURA, SATORU YAMAGUCHI and KAZUYUKI KOJIMA

  Anticancer Research July 2022, 42 (7) 3725-3733; DOI: https://doi.org/10.21873/anticanres.15862
• You have access

  Impact of Tumor Progression on Survival During Neoadjuvant Chemotherapy in Breast Cancer: A Cohort Study

  KAZUKI NOZAWA, DAIKI TAKATSUKA, YUKA ENDO, NANAE HORISAWA, YURI OZAKI, AYUMI KATAOKA, HARURU KOTANI, AKIYO YOSHIMURA, MASAYA HATTORI, MASATAKA SAWAKI and HIROJI IWATA

  Anticancer Research July 2022, 42 (7) 3735-3742; DOI: https://doi.org/10.21873/anticanres.15863
• You have access

  Impact of Older Age and Medico-social Factors on the Decision to Offer Adjuvant Chemotherapy to Patients With Breast Cancer

  KUMI NIGUMA, KANAKO MAMISHIN, YOICHI NAITO, SHOGO NOMURA, MASASHI WAKABAYASHI, SHOTA KUSUHARA, CHIKAKO FUNASAKA, TAKEHIRO NAKAO, YOKO FUKASAWA, CHIHIRO KONDOH, KENICHI HARANO, TAKAHIRO KOGAWA, NOBUAKI MATSUBARA, AKO HOSONO, TATSUYA ONISHI, TOSHIKATSU KAWASAKI and TORU MUKOHARA

  Anticancer Research July 2022, 42 (7) 3743-3751; DOI: https://doi.org/10.21873/anticanres.15864
• You have access

  Influence of Dose Reduction of Prophylactic Dexamethasone on Chemotherapy-induced Nausea and Anorexia in Patients Under 55 Years Old Treated With Anthracycline-containing Regimens

  YOSHITAKA SAITO, YOH TAKEKUMA, TAKASHI TAKESHITA and MITSURU SUGAWARA

  Anticancer Research July 2022, 42 (7) 3753-3758; DOI: https://doi.org/10.21873/anticanres.15865
• You have access

  The Geriatric Nutritional Risk Index as a Prognosis Predictor in Patients With Rectal Cancer Receiving Neoadjuvant Chemotherapy

  SOICHIRO MINAMI, NORIKATSU MIYOSHI, SHIKI FUJINO, SHINYA KATO, YUKI SEKIDO, TSUYOSHI HATA, TAKAYUKI OGINO, HIDEKAZU TAKAHASHI, MAMORU UEMURA, HIROFUMI YAMAMOTO, YUICHIRO DOKI and HIDETOSHI EGUCHI

  Anticancer Research July 2022, 42 (7) 3759-3766; DOI: https://doi.org/10.21873/anticanres.15866